Rodman & Renshaw Starts CorMedix (CRMD) at Buy
Tweet
Share
E-mailGet Alerts CRMD Hot Sheet
Price: $7.67 --0%
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 25
Rating Summary:
10 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 25
Join SI Premium – FREE
Rodman & Renshaw analyst Brandon Folkes initiates coverage on CorMedix (NASDAQ: CRMD) with a Buy rating and a price target of $13.00.
For an analyst ratings summary and ratings history on CorMedix click here. For more ratings news on CorMedix click here.
Shares of CorMedix closed at $5.65 yesterday.
You May Also Be Interested In
- Barclays Starts Centrus Energy Corp. (LEU) at Equalweight
- Noble Capital Starts Xerox (XRX) at Outperform
- Macquarie Starts Sunway Construction (SCGB:MK) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
